FindMyKOL

Arashk Motiei, MD

Basic profile

Mayo Clinic

ORCIDNone on fileNPI↗
✓ Itemized record
RegionRochester, MN · MidwestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLEmergingFindMyKOL type: RegionalLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Arashk Motiei is a Cardiology physician affiliated with Mayo Clinic. OpenAlex indexes 26 publications with 455 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
26publications

Publications indexed by OpenAlex. Counts exclude supporting files.

455citations

Citations across these publications.

7h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
10companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Industry payments

10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

All 13 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    83.2%
    Statin56.5%
    Rosuvastatin Calcium78%Atorvastatin Calcium22%
    Part D<11 patients
    Calcium channel blocker9.4%
    Amlodipine Besylate100%
    Part D<11 patients

    + 2 more classes in this area

  • Blood & clotting

    16.8%
    P2Y12 inhibitor8.9%
    Clopidogrel100%
    Part D≥13 patients
    Phosphodiesterase 3 Inhibitor7.9%
    Cilostazol100%
    Part D<11 patients
Where care is delivered (Part B)56.1% facility · 43.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

All 26 publications: search, sort and filter.Explore →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”